Immuneering Corporation
IMRX
$6.74
$0.050.75%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 227.56M | 26.36M | 35.87M | 36.14M | 50.66M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.54M | 1.37M | 2.34M | 3.44M | 4.60M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 229.10M | 27.73M | 38.21M | 39.59M | 55.26M |
|
|
|||||
| Total Current Assets | 229.10M | 27.73M | 38.21M | 39.59M | 55.26M |
| Net Property, Plant & Equipment | 4.30M | 4.46M | 4.63M | 4.79M | 4.95M |
| Long-term Investments | 6.69M | 6.69M | 6.69M | 6.69M | 6.69M |
| Goodwill | 6.69M | 6.69M | 6.69M | 6.69M | 6.69M |
| Total Other Intangibles | 328.50K | 335.80K | 343.10K | 350.40K | 357.70K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 631.30K | 841.70K | 810.90K | 1.30M | 1.30M |
| Total Assets | 241.06M | 40.06M | 50.68M | 52.71M | 68.56M |
|
|
|||||
| Total Accounts Payable | 1.60M | 2.40M | 1.31M | 1.96M | 1.94M |
| Total Accrued Expenses | 7.48M | 4.52M | 3.39M | 4.97M | 4.59M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 381.80K | 367.00K | 352.50K | 338.40K | 324.70K |
| Total Finance Division Other Current Liabilities | 80.10K | 209.70K | 56.50K | 233.70K | 59.70K |
| Total Other Current Liabilities | 80.10K | 209.70K | 56.50K | 233.70K | 59.70K |
| Total Current Liabilities | 9.55M | 7.49M | 5.11M | 7.50M | 6.92M |
|
|
|||||
| Total Current Liabilities | 9.55M | 7.49M | 5.11M | 7.50M | 6.92M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 3.53M | 3.63M | 3.73M | 3.82M | 3.92M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 13.08M | 11.12M | 8.84M | 11.33M | 10.84M |
|
|
|||||
| Common Stock & APIC | 496.72M | 282.71M | 281.18M | 265.68M | 263.96M |
| Retained Earnings | -268.74M | -253.78M | -239.34M | -224.30M | -206.24M |
| Treasury Stock & Other | -- | -- | -- | -- | 7.80K |
| Total Common Equity | 227.98M | 28.94M | 41.84M | 41.39M | 57.72M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 227.98M | 28.94M | 41.84M | 41.39M | 57.72M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 227.98M | 28.94M | 41.84M | 41.39M | 57.72M |
|
|
|||||